Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
View graph of relations



Lars Erik Kristensen is chief scientific officer (CSO) at the parker institute. He operates as part leader and part doer with the responsibility of ensuring that the scientific projects support the strategy elements of the Parker Institute.



Main research areas

Lars Erik Kristensens’ current research activities are focused around efficacy and tolerability of anti-TNF treatment and other 2nd generation biologicals in chronic arthritis both in controlled trial settings and observational cohort studies.

Current research

 Over the recent years, especially spondylarthritis have been studied also from an epidemiologic perspective. Exploring different outcome measures have gained increasing focus addressing interventions from a patient, societal, and clinical perspective.

ID: 44658929